egg-news.com - Egg-News.com By Simon M. Shane

Description: The egg production industry has a new communications resource written by the industry veteran, Simon M. Shane, Ph.D

news (24443) technology (15779) production (8269) industry (3071) veterinarian (1581) commentary (359) egg (330) egg cite (2) egg site (2) simon shane (2)

Example domain paragraphs

The USDA announced in a press release that the Agricultural Research Service is evaluating vaccines against H5N1 Highly Pathogenic Avian Influenza (HPAI).  This was confirmed on Friday 21 st in an industry association webinar by a researcher at the USDA-ARS Southeastern Poultry Research Laboratory. This is probably an exercise in reinventing the wheel, given that millions of doses of vaccine are in commercial use in numerous nations. A controlled laboratory study was recently concluded at the Wageningen Ins

The recent USDA release indicates that results will be available in May with respect to “ a single dose” program and in June for a “two-dose” regime. The USDA is evaluating two in-house developed inactivated vaccines, one based on a 2022 isolate of H5N1 derived from turkeys in Indiana. The first phase will also evaluate two commercial products available from biopharmaceutical manufacturers with two further commercial vector vaccines in June.

The current USDA policy is expressed in their statement  “Current strategy of stamping out and eradicating HPAI continues to be the most effective strategy because it works.” The question arises as for whom and by what metric? The 2022 APHIS approach has resulted in depopulation of 58 million commercial poultry over the past 14 months. The unaffected U.S. broiler, egg-production and turkey flocks were in all probability not exposed to H5N1 virus.  The recent lull in infection cannot be attributed to either

Links to egg-news.com (2)